Serotonin, cushing’s disease, and depression

Psychotherapy and Psychosomatics

Volumn 65, Issue 2, 1996, Pages 63-65

  Sonino, Nicoletta ^a   Favab, Giovanni A ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; NEUROTRANSMITTER; SEROTONIN; SEROTONIN RECEPTOR;

CORTICOTROPIN RELEASE; CUSHING DISEASE; DEPRESSION; EDITORIAL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM;

EID: 0029864939     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000289048     Document Type: Article

References (44)

1. Carroll BJ: Psychoendocrine relationships in affective disorders, in Hill OW (ed): Modern Trends in Psychosomatic Medicine. London. Butterworths, 1976, pp 121-153.
2. Krieger DT: Physiopathology of Cushing’s disease. EndocrRcv 1983;4:22-43.
3. Cushing II: Psychic disturbances associated with disorders of the ductless glands. Am J Insanity 1913:69:965-990.
4. Gold PW, Loriaux DL. Roy A, Kling M, Calabrese JR, Kellner CH. Nieman LK. Post RM, Pickar D. Gallucci W. Avgcrinos P. Paul S, Oldfield EH, Cutler GB, Chrousos GP: Responses to corticotropin-releasing hormone in the hypcrcortisolism of depression and Cushing's disease. N Engl J Med 1986:314:1329-1335.
5. Dorn LD, Burgess ES, Dubbcr B, Simpson SE, Friedman T, Kling M, Gold PW, Chrousos GP: Psychopathology in patients with endogenous Cushing’s syndrome: Atypical or melancholic features. Clin Endocrinol 1995;43:433-442.
6. Fava GA: Affective disorders and endocrine disease. New insights from psychosomatic studies. Psychosomatics 1994;35:341-353.
7. Leonard BE: Serotonin receptors and their function in sleep, anxiety disorders and depression. Psychother Psychosom 1996:65:66-75.
8. Lewis DA. Sherman BM: Serotonergic stimulation of adrenocorticotropin secretion in man. J Clin Endocrinol Metab 1984:58:1458-1462.
9. Gartside SE. Cowen PJ: Mediation of ACTH and prolactin responses to 5-HTP by 5HT; receptors. Eur J Pharmacol 1990; 179:103-109.
10. A-2C receptors. J Pharmacol Exp Ther 1994:271: 1645-1655.
11. Calogero AE, Bagdy G. Moncada ML, D’Agata R: Effect of selective serotonin agonists on basal, corticotrophin-releasing hormone and vasopressin-induced ACTH release in vitro from rat pituitary cells. J Endocrinol 1993; 136:381-387.
12. Calogero AE, Bagdy G, Szemeredi K. Tartaglia ME. Gold PW. Chrousos GP: Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 1990:126:1888-1894.
13. Lesch KP. Sohule K. Polen B. Schoellnhammcr G, Rupprecht R. Schulte HM: Corticotropin and cortisol secretion after central 5-hydroxy-tryptamine-1 A (5-Hti,\) receptor activation. J Clin Endocrinol Methab 1990:70:670-674.
14. Areceptor antagonist WAY100635. F.urJ Pharmacol 1994:264:95-97.
15. Lcfebvre H, Contcssc V. Dclarne C. Fenillolcy M, Hery F. Grisc P. Raynaud G, Vcrhofstad AAJ, Wolf LM. Vandry H: Scrotonin-induccd stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin receptor subtype. Neuroscience 1992;47:999-1007.
16. Levy AD. Li Q. Rittenhouse PA, van dc Kar LD: Investigation of the role of 5-HTj receptors in the secretion of prolactin. ACTH and renin. Neuroendocrinology 1993:58:65-70.
17. Calogcro AE, Bagdy G. Burrello N, Polosa P, D'Agata R: Role for serotonin! receptors in the control of adrenocorticotropic hormone release from rat pituitary cell cultures. Eur J Endocrinol 1995:133:251-254.
18. De Souza EB: Serotonin and dopamine receptors in the rat pituitary gland. Endocrinology 1986:119:1534-1542.
19. Johns MA, Azmitia EC. Krieger DT: Specific in vitro uptake of serotonin by cells in the anterior pituitary' of the rat. Endocrinology 1982: 110:754-760.
20. 1Aagonists and by 5-HTi and 5-HTi antagonists. Psychoneuroendocrinology 1995:20:239-257.
21. Maes M. Meltzer HY. d’Hondt PD. Cosyns P. Blockx P: Effects of serotonin precursors on the negative feedback effects of glucocorticoids on hypothalamic-pituitary-adrenal axis function in depression. Psychoncuroendocrinology 1995;20:149-167.
22. Sonino N, Fava GA, Grandi S, Mantero F. Bos-caro M: Stressful life events in the pathogenesis of Cushing's syndrome. Clin Endocrinol 1988; 29:617-623.
23. Sonino N, Fava GA, Boscaro M: A role for life events in the pathogenesis of Cushing's disease. Clin Endocrinol 1993;38:261-264.
24. Fava GA. Munari F. Pavan L, Kellner R: Life events and depression. J Affect Disord 1981;3: 159-165
25. Harbuz MS. Lightman SI.: Stress and the hypo-thalamo-pituitary-adrenal axis. J Endocrinol 1992;134:327-339.
26. Deakin JFW: The clinical anxiolytic and antidepressant efficacy of drugs with action on serotonin systems; in den Boer JA, Sitsen JM (cds); Handbook of Depression and Anxiety. New York. Dekker, 1994, pp 447-472.
27. Biller BMK: Pathogenesis of pituitary' Cushing's syndrome. Endocrinol Metab Clin N Am 1994:23:547-555.
28. Fiekers JF. Konopka LM: Scrotonin-induccd changes in membrane potential and cytosolic free calcium in a clonal pituitary cell line(AtT-20) of cultured mouse corticotropcs. Life Sci 1994:55:15-26.
29. Biondi M, Costantini A. Parisi A: Can loss and grief activate latent neoplasia? A clinical case of possible interaction between genetic risk and stress in breast cancer. Psychother Psychosom 1996:65:102-105.
30. Martire M, Pistritto G. Prcziosi P: Different regulation of serotonin receptors following adrenal hormone imbalance in the rat hippocampus and hypothalamus. J Neural Transm 1989; 78:109-120.
31. Kuroda Y, Mikuni M. Ogawa T, Takahashi K: Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HTy receptor binding sites in neocortex of rat forebrain and 5HTi receptor-mediated wet-dog shake behaviors. Psychopharmacology 1992: 108:27-32.
32. Sonino N, Fava GA. Belluardo P. Girelli ME. Boscaro M: Course of depression in Cushing's syndrome. Horm Res 1993:39:202-206.
33. Sonino N. Boscaro M, Fallo F. Fava GA: Potential therapeutic effects of ritanserin in Cush-ing'sdisease. JAMA 1992:267:1073.
34. Sonino N: The use of kétoconazole as an inhibitor of steroid production. N Engl J Med 1987: 317:812-818.
35. Fava GA, Kellner R: Prodromal symptoms in affective disorders. Am J Psychiatry' 1991:148: 823-330.
36. Ghadirian AM, Engclsmann F. Dhar V. Fili-pini D. Keller R. Chouinard G, Murphy BEP: The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment. Biol Psychiatry 1995;37:369-375.
37. Wolkowitz OM, Reus VI, Manfrcdi F. Ingbar J. Brizcndine L, Weingartner H: Kétoconazole administration in hypcrcortisolcmic depression. Am J Psychiatry' 1993;150:810-812.
38. Thakore JH, Dinan TG: Cortisol synthesis inhibition: A new' treatment strategy for the clinical and endocrine manifestation of depression. Biol Psychiatry 1995:37:364-368.
39. Arana GW, Santos AB, Laraia MT. McLeod Bryant S, Beale MD, Rames LJ, Roberts JM. Dias JK. Molloy M: Dexamethasone for the treatment of depression. Am J Psychiatry 1995:152:265-267.
40. Fava GA: The concept of recovery in affective disorders. Psychother Psychosom 1996:65:2-13.
41. Fava GA: Holding on: Depression, sensitization by antidepressant drugs, and the prodigal experts. Psychother Psychosom 1995:64:57-61.
42. Sonino N, Fava GA, Fallo F, Boscaro M: Psychological distress and quality of life in endocrine disease. Psychother Psychosom 1990:54: 140-144.
43. Fava GA. Sonino N. Morphy MA: Psychosomatic view of endocrine disorders. Psychother Psychosom 1993:59:20-33.
44. Ilellhammer DM, Wade S: Endocrine correlates of stress vulnerability. Psychother Psychosom 1993:60:8-17.